Evidence map›Paper›PMID 25564306›Full record

ArticleJournal of the American Chemical Society2015

An unusual peroxo intermediate of the arylamine oxygenase of the chloramphenicol biosynthetic pathway.

Thomas M Makris, Van V Vu, Katlyn K Meier, Anna J Komor, Brent S Rivard, Eckard Münck, Lawrence Que, John D Lipscomb

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 85 citations in OpenAlex.

  1. Heme oxygenase-like dimetal oxidases and oxygenases.Biochemical Society transactions · 2026
    Review
  2. Article
  3. Article
  4. Heme Oxygenase-Like Metalloenzymes.Annual review of biochemistry · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Ligand-Constraint-Induced Peroxide Activation for Electrophilic Reactivity.Angewandte Chemie (International ed. in English) · 2021
    Article
  13. Article
  14. Structure and assembly of the diiron cofactor in the heme-oxygenase-like domain of theProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  15. Article
  16. A Peroxodiiron(III/III) Intermediate Mediating BothJournal of the American Chemical Society · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Thomas M MakrisDepartment of Biochemistry, Molecular Biology, and Biophysics, ¶Center for Metals in Biocatalysis, and ‡Department of Chemistry, University of Minnesota , Minneapolis, Minnesota 55455, United States.
Van V Vu
Katlyn K Meier
Anna J Komor
Brent S Rivard
Eckard Münck
Lawrence Que
John D Lipscomb
University of Minnesota · USCarnegie Mellon University · USInstitute of Molecular Biology and Biophysics · RUTwin Cities Orthopedics · US

Funding

Synthetic Models and Spectroscopy of Nonheme Diiron EnzymesR01GM038767 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI QUE, LAWRENCE · 1987 to 2018
$5.8M
Roles of protein structure and diiron cluster chemistry in oxygen activationR01GM100943 · NIGMS · UNIVERSITY OF MINNESOTA · PI LIPSCOMB, JOHN D · 2012 to 2015
$1.2M
NIGMS NIH HHS GM100943NIGMS NIH HHS GM38767NIGMS NIH HHS R01 GM038767NIGMS NIH HHS R01 GM100943
6 · The paper itself

Abstract

Streptomyces venezuelae CmlI catalyzes the six-electron oxygenation of the arylamine precursor of chloramphenicol in a nonribosomal peptide synthetase (NRPS)-based pathway to yield the nitroaryl group of the antibiotic. Optical, EPR, and Mössbauer studies show that the enzyme contains a nonheme dinuclear iron cluster. Addition of O(2) to the diferrous state of the cluster results in an exceptionally long-lived intermediate (t(1/2) = 3 h at 4 °C) that is assigned as a peroxodiferric species (CmlI-peroxo) based upon the observation of an (18)O(2)-sensitive resonance Raman (rR) vibration. CmlI-peroxo is spectroscopically distinct from the well characterized and commonly observed cis-μ-1,2-peroxo (μ-η(1):η(1)) intermediates of nonheme diiron enzymes. Specifically, it exhibits a blue-shifted broad absorption band around 500 nm and a rR spectrum with a ν(O-O) that is at least 60 cm(-1) lower in energy. Mössbauer studies of the peroxo state reveal a diferric cluster having iron sites with small quadrupole splittings and distinct isomer shifts (0.54 and 0.62 mm/s). Taken together, the spectroscopic comparisons clearly indicate that CmlI-peroxo does not have a μ-η(1):η(1)-peroxo ligand; we propose that a μ-η(1):η(2)-peroxo ligand accounts for its distinct spectroscopic properties. CmlI-peroxo reacts with a range of arylamine substrates by an apparent second-order process, indicating that CmlI-peroxo is the reactive species of the catalytic cycle. Efficient production of chloramphenicol from the free arylamine precursor suggests that CmlI catalyzes the ultimate step in the biosynthetic pathway and that the precursor is not bound to the NRPS during this step.

Indexed as

Biosynthetic PathwaysChloramphenicolElectron Spin Resonance SpectroscopyModels, MolecularOxygenasesPeroxidesSpectroscopy, MossbauerSpectrum Analysis, RamanStreptomycesChloramphenicolOxygenasesPeroxides

Identifiers

PMID25564306
PMCPMC4318726
OpenAlexW2044218686

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.